Study Design. Retrospective study of 55 consecutive patients with spinal metastases secondary to breast cancer who underwent surgery.
Because advances in tumor diagnosis and treatment have improved the prognosis of patients with cancer, the incidence of clinically apparent metastatic disease has increased. 1 Spinal metastases are a very common manifestation of bony metastasis. 2, 3 Of vertebral metastases, 75% originate from carcinomas of the breast, prostate, lung, thyroid gland, and kidney. 4 Metastases of unknown primary tumors account for only 3% to 4%. 5 Spinal metastases are most often located in the vertebral body and in the peridural space, a dorsal localization is a rare finding. 1 Surgery has to strive for the maximum palliative effect, including the reduction of pain and maintenance or restoration of function and stability of the spine, with a minimum of operative morbidity and mortality.
For the surgeon involved in treating the individual patient, it is not easy to choose the optimal treatment. The decision should be strongly influenced by the predicted survival. Therefore, Tokuhashi et al 6 developed a simple scoring system for the preoperative evaluation of the prognosis for patients with spinal metastases. This score consists of the sum of 6 parameters that are used to measure the severity of the disorder: (1) general condition of the patient, (2) the number of extraspinal bone metastases, (3) the number of vertebral metastases, (4) the number of metastases to the major internal organs, (5) the primary site of cancer, and (6) the spinal cord palsy. Each parameter is rated between 0 and 2. Zero signifies the worst prognosis (Table 1) .
Tokuhashi et al 6 proposed a survival of Յ3 months for patients with a total score of Յ5, a survival of Յ12 months for those with Յ8 points, and a survival of Ն12 months in patients with a total score of Ն9 points. Therefore, these investigators recommend excisional surgery of metastases when the total score reaches Ն9 and palliative treatment when the score is Յ5. Recently, Tokuhashi et al 8 modified this score by a more differentiated grouping of the primary tumor site from 0 to 5. This modification leads to a total score from 0 to 15 (Table 1 Patients with spinal metastases and an intermediate or good prognosis seem to benefit from a more radical (excisional) removal of metastatic spine lesions. 9 -11 Although all surgical procedures remain palliative by definition, evaluation of the prognosis is necessary to make the decision for surgical procedures (i.e., dorsoventral approach vs. isolated posterior instrumentation). Stabilization and restoration of the anterior spinal column after surgical removal of the diseased vertebra is, as in acute traumatic spinal lesions with a collapse of the vertebra, also recommended in patients with spinal instabilities caused by metastases with a good long-term prognosis. Therefore, calculation of the survival is not only useful to improve the prognosis with a more radical surgical procedure 9 -11 but also to prevent mechanical complications of an isolated dorsal instrumentation in the case of predicted long-term survival. 4, [12] [13] [14] [15] [16] In these patients, reconstruction of the vertebral body following vertebral removal should provide sufficient long-term stability.
In times of decreasing finances, the indication for surgery, especially when using costly implants in patients with tumor with a significantly reduced life expectancy, should be based on proved algorithms and scores. The present study was performed to compare the survival predicted by the Tokuhashi score, 6 with the definitive survival of patients with spinal metastases caused by breast cancer because the origin of the primary tumor has substantial influence on the survival. 8 Including only patients with the same type of cancer reduces the number of variable parameters in the Tokuhashi score from 6 to 5.
Patients and Methods
In this retrospective study, 55 patients with spinal metastases secondary to breast cancer underwent surgery for spine fusion for reduction of pain or for neurologic deficits between September 1984 and September 2003. Histologic evaluation verified breast cancer as the primary tumor in all cases. Before surgery, patients were examined with plain anterior-posterior and lateral radiographs of the affected spinal segment, computerized tomography with sagittal reconstructions of the involved vertebra, and magnetic resonance imaging focused on the affected spinal segment to establish the extent of the osseous and spinal canal involvement. A systemic search for other metastases was performed in cooperation with the gynecologists. This process included clinical evaluation, mammography of the affected and contralateral mamma and transvaginal, and abdominal sonography. The staging was completed by plain radiographs of the thorax to detect pulmonary metastases and bone scan to detect other osseous metastases, especially in the spine. Computerized tomography of the chest, abdomen, and brain was performed in each patient with suspicious clinical findings. In addition, the preoperative Tokuhashi score 6 was calculated for all patients ( Table 1 ). The survival dates were censored at February 3, 2004.
All findings were entered into an Excel database (Microsoft, Corp., Redmond, WA) to ensure that all vertebral, bony, and visceral metastases would be listed and analyzed in the same way, and enable comparisons to be made wherever possible. The statistical unit of analysis was the patient, and statistical analysis was performed on the 55 patients available for the follow-up study. To test the prognostic value of the Tokuhashi score, its total number of points was evaluated in all patients. The possibility to evaluate this preoperative score retrospectively was described by Enkaoua et al. 17 Statistical analyses were performed using the log-rank test for univariate analysis. Survival curves were created using the Kaplan-Meier life table analyses. A P value Ͻ0.05 (2-tailed) was considered significant.
Results
The mean survival of all study patients was 27.2 Ϯ 28.6 months (range 0.8Ϫ132.2; median 16.2). At the end of the study, 46 patients (83.6%) had died. In 9 surviving patients (16.4%), mean observation period was 37.2 Ϯ 33.9 months (range 9.4Ϫ112.5; median 24.9). Only 1 patient has been observed less than 12 months. The Tokuhashi score 6 was calculated for all patients (Table 1) , and the number of patients with the same score is depicted in Figure 1 .
For the palliative group (n ϭ 7; 12.7%), the survival was predicted according to Tokuhashi et al 6 to be less than 3 months. In our evaluation (Table 2) , these patients revealed a mean survival of 11.5 Ϯ 17.2 months (range 0.8Ϫ49.4; median 5.0). The indifferent group (n ϭ 26; 47.3%) had a predicted survival of Յ12 months. However, our group showed a mean survival of 21.5 Ϯ 18.4 months (range 1.9Ϫ64.9; median 14.8). The excisional group (n ϭ 22; 40%) had a predictive survival of Ն12 months and revealed in our study group a mean survival of 38.9 Ϯ 36.7 months (range 2.7-132.2; median 25.6). The prognostication of the survival interval using the original evaluation of Tokuhashi et al 6 was significant (P Ͻ 0.0103) (Figure 2A) .
Because the original evaluation of the Tokuhashi score has shown only a limited correlation between predicted and real survival, classification of the Tokuhashi score was modified. There were 4 patients (7.3%) included in the first group (0 -4 points instead of 0 -5 points), with a mean survival of 2.9 Ϯ 2.0 months (range 0.8 -5.0; median 2.9). The second group (5-8 points instead of 6 -8 points) included 29 patients (52.7%) with a mean survival of 21.7 Ϯ 18.4 months (range 1.9 -64.9; median 14.4). The third group (Ն9 points) included 22 patients (40%), with a mean survival of 38.9 Ϯ 36.7 months (range 2.7-132.2; median 25.6). The modified score showed a higher significance for the prognosticated survival (P Ͻ 0.0001) than the original one ( Figure 2B ). The differences among the original, revised, and modified evaluations of the Tokuhashi score are listed in Table 2 .
Discussion
This study confirms the value of the Tokuhashi score to predict the time of survival in females with spinal metastases caused by breast carcinoma. However, our modification could significantly improve the predictive value of the score to estimate life expectancy. Therefore, the score can facilitate surgical planning in spinal metastases in breast carcinoma. Survival is influenced by various isolated parameters. According to Tokuhashi et al, 6 these parameters should be combined in a significant but easy, usable score to evaluate the survival prognosis. Therefore, these investigators proposed a prognostic scoring system, taking 6 variables into account, for the preoperative evaluation of patients with spinal metastases.
The influence of the general medical condition for the prediction of the survival is controversially discussed. For nonneurologic cases, the Karnofsky index has proved to be effective. 18 If the Karnofsky index of patients with spinal metastases is more than 70%, the survival period will increase. 19 When the general state is not good (i.e., Karnofsky index less than 40%), palliative treatments other than surgery should be considered for patients without neurologic deficits. 18 Figure 1. Total number of score points of the Tokuhashi evaluation score 6 for our study patients (n ϭ 55). Figure 2 . A, Predictive survival of the Tokuhashi score regarding the prognostic groups according to Tokuhashi. 6 Small dashes (----) indicate patients with a total number of Յ5 score points. Long dashes (---) show patients with a total number of 6 -8 score points. Solid line (-) illustrates patients with a total number of Ն9 points. B, Predictive survival of the Tokuhashi score with modified restrictions of the prognostic groups. Small dashes (----) indicate patients with a total number of Յ4 score points. Long dashes (---) show patients with a total number of 5-8 score points. Solid line (-) indicates patients with a total number of Ն9 score points.
The survival is significantly lower for patients with bone metastases combined with additional visceral spread in contrast to isolated bony metastases, and significantly lower for patients with multiple bony in contrast to solitary bony metastases. 20 Therefore, the bony and visceral spread, and the extent and number of bony metastases have been accepted as a predictive factor for the patient's survival. 4,6,17,20 -22 Variable survival rates have been reported by several investigators dependent on the primary site of tumor.
18,23-29 Tatsui et al 27 evaluated the 1-year survival of 425 patients with spinal metastases of different origin after detection by bone scan. They reported a 1-year survival rate of 83.3% for patients with prostatic cancer, 77.7% for those with breast cancer, 51.2% for those with renal cancer, 44.6% for patients with uterine cancer, 21.7% for patients with lung cancer, and 0% of those with gastric cancer. Therefore, Tokuhashi et al 6 included the site of tumor as one major prognostic factor influencing the survival. Enkaoua et al 17 confirmed the prognostic value of the Tokuhashi score but recommended assigning 0 points for carcinomas of unknown primary. Oberndorfer and Grisold 30 followed 38 patients with different primary tumors and could show that the Tokuhashi score decreased 3 months after various therapies from 0.8 to 2.4 score points. Riegel et al 31 also showed a significant correlation between score and survival for 139 patients.
Paraplegia is also a controversially discussed prognostic factor in patients with spinal metastases. It has been reported that the rapidity of the onset of muscular weakness has a considerable bearing on the ultimate prognosis. A delay of less than 24 hours between the onset of the symptoms and appearance of a full-blown neurologic syndrome leads to a poor prognosis no matter what treatment is offered. 32 In contrast, Spiegel et al 33 reported that the presence of a neurologic deficit did not significantly influence the survival among patients with melanoma. Enkaoua et al 17 also reported that epidural metastases were not significantly associated with the length of survival. Patients with paraplegia seem to die sooner because of progression of their cancer, but not for paraplegia itself. Tomita et al 34 did not accept the neurologic state as a prognostic factor for their system of survival prognostication in spinal metastases. They also proposed the surgical classification of the spinal tumors based only on 3 factors: (1) grade of malignancy of the primary tumor; (2) visceral metastases to vital organs (lung, liver, kidneys, and brain); and (3) bone metastases. 11, 34, 35 The score ranges between 2 and 10, and the lower the total numbers of points, the better the predicted survival, but the primary cancer type, generalized metastases, neurologic impairment, or general state of the patient were not considered. 34 Tokuhashi 6 and Enkaoua 17 et al indicate surgery without regarding biomechanical aspects in a predicted long-time-survival of the patient. However, to avoid the problems of isolated dorsal instrumentations during further follow-up, stabilization and restoration of the spine in patients with a good prognosis is necessary. 4, [12] [13] [14] [15] [16] Harrington 32 designed a 5-category classification for spinal metastases to evaluate patients for surgical and nonsurgical indications: The classification regards only bone destruction and neurologic compromise: (1) no significant neurologic involvement, (2) involvement of bone without collapse or instability, (3) major neurologic impairment (sensory or motor) without significant involvement of the bone, (4) vertebral collapse with pain resulting from mechanical causes or instability but with no significant neurologic involvement, and (5) vertebral collapse or instability combined with major neurologic impairment. He recommended that patients in categories 1Ϫ3 be treated with radiotherapy, chemotherapy, or hormonal manipulation, and patients in categories 4 or 5 should consider undergoing surgery.
Based on a 2-column concept, Kostuik et al 36 make their decision for surgical intervention in spinal instability. The anterior column includes the vertebral body with the cortex and is further divided into 4 quadrants, an anterior and posterior, and a left and right part of the vertebral body. The posterior column consists of pedicles, laminae, and spinal cord, and is divided into a left and right part. If no more than 2 parts of the 6 parts are destroyed, spinal stability is expected.
McLain and Weinstein 37 suggested that the optimal surgical approach should be based on the extent of bony involvement. They divided the vertebra into 4 zones to select adequate surgery: (1) process spinous to pars interarticularis and the inferior facets; (2) the superior articular facet, the transverse process, and the pedicle; (3) anterior three fourths of the vertebral body; and (4) the posterior one fourth of the vertebral body. Tumor extension was classified as AϪC for intraosseous, extraosseous, and distant tumor spread.
According to Taneichi et al, 38 surgery should be considered when the risk of impending collapse is significant: more than 50% to 60% involvement of the vertebral body with no destruction of adjacent structures, or 25% to 30% involvement with costovertebral joint destruction in the thoracic spine and 35% to 40% involvement of the vertebral body, or 20% to 25% involvement with destruction of the posterior elements in the thoracolumbar and lumbar spine.
Conclusions
In our study, patients with spinal metastasis secondary to breast cancer survived longer (mean survival 27.2 Ϯ 28.6 months; range 0.8Ϫ132.2 months; median 16.2 months) than estimated by the Tokuhashi score and shown by Coleman 39 (median survival 20 months). Using a modified grouping of the Tokuhashi score, we could identify patient groups with a mean survival of Ͻ3 months (group 1), 21.7 months (group 2), and 38.9 months (group 3). In connection with biomechanical aspects, this score allows adaptation of the therapy to the expected survival. No surgery in group 1 with a very limited life expectancy, a dorsal approach in group 2, and a dorsoventral approach in group 3. 40, 41 The revisions performed by Tokuhashi (written communication, June 2004) do not change the results of this study. However, a prospective study will ultimately determine the true value of this score.
Key Points
• Prognostic factors in patients with spinal metastases strongly influence the surgical pathway.
• Spinal metastases are a very common manifestation of bony metastases, 75% of them originate from carcinomas of the breast, prostate, lung, thyroid, and kidney.
• Breast cancer is the most common female cancer with frequent vertebral metastases.
• Life expectancy is a key factor for surgical planning.
• Outcome analysis in spinal metastases assigns a value to prognostic scores.
